TMEM202-AS1

Across TCGA pan-cancer cohorts, TMEM202-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated TMEM202-AS1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher TMEM202-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TMEM202-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and ACC show a favorable association.

UVM, UCS, and CHOL are the cancer types where TMEM202-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	III,IV	0.245	0.836	.002	82	view →
UCS	OS	Tertile	III,IV	0.719	0.228	.001	28	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	21	view →
ACC	DFS	Quartile	III,IV	0.517	0.071	.006	17	view →
LUSC	OS	Quartile	All	0.839	0.688	.007	15	view →
LGG	OS	Quartile	All	0.723	0.885	.001	13	view →
KIRP	DFS	Tertile	All	0.489	0.865	.005	13	view →
KIRC	DFS	Quartile	All	0.790	0.522	.004	12	view →
LUAD	DFS	Median	IV	0.406	0.817	.007	12	view →
MESO	DFS	Tertile	II,III,IV	0.275	0.686	.012	12	view →
STAD	DFS	Median	IV	0.212	0.648	.026	9	view →
CESC	DFS	Median	All	0.613	0.472	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

TMEM202-AS1–UVM (OS)

Open the UVM breakdown →